
The global market for Roxadustat API was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Roxadustat API, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Roxadustat API by region & country, by Type, and by Application.
The Roxadustat API market size, estimations, and forecasts are provided in terms of sales volume (Tons) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Roxadustat API.
Market Segmentation
By Company
DR REDDYS LABORATORIES LTD
MAITHRI DRUGS PRIVATE LTD
Sichuan Ren'an Pharmaceutical
FibroGen (China) Pharmaceuticals
Segment by Type:
±Ê³Ü°ù¾±³Ù²â≥99%
Purity<99%
Segment by Application
Tablet
Capsule
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Roxadustat API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Roxadustat API in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Roxadustat API in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Market Overview
1.1 Roxadustat API Product Introduction
1.2 Global Roxadustat API Market Size Forecast
1.2.1 Global Roxadustat API Sales Value (2019-2030)
1.2.2 Global Roxadustat API Sales Volume (2019-2030)
1.2.3 Global Roxadustat API Sales Price (2019-2030)
1.3 Roxadustat API Market Trends & Drivers
1.3.1 Roxadustat API Industry Trends
1.3.2 Roxadustat API Market Drivers & Opportunity
1.3.3 Roxadustat API Market Challenges
1.3.4 Roxadustat API Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Roxadustat API Players Revenue Ranking (2023)
2.2 Global Roxadustat API Revenue by Company (2019-2024)
2.3 Global Roxadustat API Players Sales Volume Ranking (2023)
2.4 Global Roxadustat API Sales Volume by Company Players (2019-2024)
2.5 Global Roxadustat API Average Price by Company (2019-2024)
2.6 Key Manufacturers Roxadustat API Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Roxadustat API Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Roxadustat API
2.9 Roxadustat API Market Competitive Analysis
2.9.1 Roxadustat API Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Roxadustat API Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Roxadustat API as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 ±Ê³Ü°ù¾±³Ù²â≥99%
3.1.2 Purity<99%
3.2 Global Roxadustat API Sales Value by Type
3.2.1 Global Roxadustat API Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Roxadustat API Sales Value, by Type (2019-2030)
3.2.3 Global Roxadustat API Sales Value, by Type (%) (2019-2030)
3.3 Global Roxadustat API Sales Volume by Type
3.3.1 Global Roxadustat API Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Roxadustat API Sales Volume, by Type (2019-2030)
3.3.3 Global Roxadustat API Sales Volume, by Type (%) (2019-2030)
3.4 Global Roxadustat API Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Tablet
4.1.2 Capsule
4.2 Global Roxadustat API Sales Value by Application
4.2.1 Global Roxadustat API Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Roxadustat API Sales Value, by Application (2019-2030)
4.2.3 Global Roxadustat API Sales Value, by Application (%) (2019-2030)
4.3 Global Roxadustat API Sales Volume by Application
4.3.1 Global Roxadustat API Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Roxadustat API Sales Volume, by Application (2019-2030)
4.3.3 Global Roxadustat API Sales Volume, by Application (%) (2019-2030)
4.4 Global Roxadustat API Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Roxadustat API Sales Value by Region
5.1.1 Global Roxadustat API Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Roxadustat API Sales Value by Region (2019-2024)
5.1.3 Global Roxadustat API Sales Value by Region (2025-2030)
5.1.4 Global Roxadustat API Sales Value by Region (%), (2019-2030)
5.2 Global Roxadustat API Sales Volume by Region
5.2.1 Global Roxadustat API Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Roxadustat API Sales Volume by Region (2019-2024)
5.2.3 Global Roxadustat API Sales Volume by Region (2025-2030)
5.2.4 Global Roxadustat API Sales Volume by Region (%), (2019-2030)
5.3 Global Roxadustat API Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Roxadustat API Sales Value, 2019-2030
5.4.2 North America Roxadustat API Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Roxadustat API Sales Value, 2019-2030
5.5.2 Europe Roxadustat API Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Roxadustat API Sales Value, 2019-2030
5.6.2 Asia Pacific Roxadustat API Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Roxadustat API Sales Value, 2019-2030
5.7.2 South America Roxadustat API Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Roxadustat API Sales Value, 2019-2030
5.8.2 Middle East & Africa Roxadustat API Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Roxadustat API Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Roxadustat API Sales Value
6.2.1 Key Countries/Regions Roxadustat API Sales Value, 2019-2030
6.2.2 Key Countries/Regions Roxadustat API Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Roxadustat API Sales Value, 2019-2030
6.3.2 United States Roxadustat API Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Roxadustat API Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Roxadustat API Sales Value, 2019-2030
6.4.2 Europe Roxadustat API Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Roxadustat API Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Roxadustat API Sales Value, 2019-2030
6.5.2 China Roxadustat API Sales Value by Type (%), 2023 VS 2030
6.5.3 China Roxadustat API Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Roxadustat API Sales Value, 2019-2030
6.6.2 Japan Roxadustat API Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Roxadustat API Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Roxadustat API Sales Value, 2019-2030
6.7.2 South Korea Roxadustat API Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Roxadustat API Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Roxadustat API Sales Value, 2019-2030
6.8.2 Southeast Asia Roxadustat API Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Roxadustat API Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Roxadustat API Sales Value, 2019-2030
6.9.2 India Roxadustat API Sales Value by Type (%), 2023 VS 2030
6.9.3 India Roxadustat API Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 DR REDDYS LABORATORIES LTD
7.1.1 DR REDDYS LABORATORIES LTD Company Information
7.1.2 DR REDDYS LABORATORIES LTD Introduction and Business Overview
7.1.3 DR REDDYS LABORATORIES LTD Roxadustat API Sales, Revenue and Gross Margin (2019-2024)
7.1.4 DR REDDYS LABORATORIES LTD Roxadustat API Product Offerings
7.1.5 DR REDDYS LABORATORIES LTD Recent Development
7.2 MAITHRI DRUGS PRIVATE LTD
7.2.1 MAITHRI DRUGS PRIVATE LTD Company Information
7.2.2 MAITHRI DRUGS PRIVATE LTD Introduction and Business Overview
7.2.3 MAITHRI DRUGS PRIVATE LTD Roxadustat API Sales, Revenue and Gross Margin (2019-2024)
7.2.4 MAITHRI DRUGS PRIVATE LTD Roxadustat API Product Offerings
7.2.5 MAITHRI DRUGS PRIVATE LTD Recent Development
7.3 Sichuan Ren'an Pharmaceutical
7.3.1 Sichuan Ren'an Pharmaceutical Company Information
7.3.2 Sichuan Ren'an Pharmaceutical Introduction and Business Overview
7.3.3 Sichuan Ren'an Pharmaceutical Roxadustat API Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Sichuan Ren'an Pharmaceutical Roxadustat API Product Offerings
7.3.5 Sichuan Ren'an Pharmaceutical Recent Development
7.4 FibroGen (China) Pharmaceuticals
7.4.1 FibroGen (China) Pharmaceuticals Company Information
7.4.2 FibroGen (China) Pharmaceuticals Introduction and Business Overview
7.4.3 FibroGen (China) Pharmaceuticals Roxadustat API Sales, Revenue and Gross Margin (2019-2024)
7.4.4 FibroGen (China) Pharmaceuticals Roxadustat API Product Offerings
7.4.5 FibroGen (China) Pharmaceuticals Recent Development
8 Industry Chain Analysis
8.1 Roxadustat API Industrial Chain
8.2 Roxadustat API Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Roxadustat API Sales Model
8.5.2 Sales Channel
8.5.3 Roxadustat API Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
DR REDDYS LABORATORIES LTD
MAITHRI DRUGS PRIVATE LTD
Sichuan Ren'an Pharmaceutical
FibroGen (China) Pharmaceuticals
Ìý
Ìý
*If Applicable.
